ADGRG2 and hepatocellular carcinoma: In addition, research has found that miR-326 inhibited the proliferation and migration of hepatocellular carcinoma cells by targeting ADGRG2, and the combination of ADGRG2 and miR-326 exhibited better diagnostic potential.